NIH Public Access
- 作者Ferrand, Yann; Klein, Emmanuel; Barwell, Nicholas P; Crump, Matthew P; Jiménez-, Jesus; Vicent, Cristina; Boons, Geert-jan; Ingale, Sampat; Davis, Anthony P; Ferrand, Y; Klein, E; Barwell, N P; Crump, M P; Davis, Prof A P
- 卷第48卷
- 期第10期
- 文件大小1627.74KB
- 发表时间2010
- DOI10.1002/anie.200804905.A
- 页码1775-1779
Editorial: Editorial and editorial board changesBen Greenebaum · 2003
Peripatetic: An Editorial Riff || Editorial: “Peripatetic: An Editorial Riff”Robert S. Fogarty · The Antioch Review · 2012
LAS SOCIEDADES DEL ULTIMO PERIODO DE LA HISTORIA ANTIGUA DE AMERICA || COMENTARIO EDITORIAL / EDITORIAL COMMENT / COMMENTAIRE EDITORIAL / COMENTÁRIO EDITORIALRevista de Arqueología Americana · 1995-1993
Editorial board & international editorial advisory board1998
Editorial board & international editorial advisory board1999
Editorial board & international editorial advisory board1999
Editorial board & international editorial advisory board1999
Editorial/Editorial2008
Clinical comparability and European biosimilar regulationsSchellekens, Huub; Moors, Ellen · 2010
How similar do 'biosimilars' need to be?Schellekens, Huub · 2004
Bioequivalence and the immunogenicity of biopharmaceuticalsSchellekens, Huub · 2002
Interchangeability, immunogenicity and biosimilarsEbbers, Hans C; Crow, Stacy A; Vulto, Arnold G; Schellekens, Huub · Nature Biotechnology · 2012
What's in a name?Schellekens, Huub · Nature Biotechnology · 2014
Biosimilars or semi-similars?Schellekens, Huub; Moors, Ellen · Nature Biotechnology · 2015
Biosimilars need comparative clinical dataCasadevall, Nicole; Thorpe, Robin; Schellekens, Huub · Kidney International · 2011